Loading...
OTCM
EDNSF
Market cap26mUSD
Jul 07, Last price  
0.05USD
Name

Eden Research PLC

Chart & performance

D1W1MN
OTCM:EDNSF chart
P/E
—
P/S
8.35
EPS
—
Vol. 1Y
—
Shs. 5Y
9.42%
Rev. 5Y
23.18%
Div Yld LY
—
Div Yld TTM
—
Revenues
4m
-9.78%
102,559360,78884,003193,000172,00091,00043,59080,22399,855883,312391,9581,877,1872,774,2721,825,5011,368,9881,228,5801,827,1713,192,0274,302,6033,881,812
Net income
-2m
L+2.67%
-4,092,332-2,463,869-2,101,237-1,727,000-3,251,000-3,284,000-2,317,134-1,587,909-2,969,468-1,157,103-1,831,092-639,093-334,951-1,144,703-2,270,347-2,788,973-2,237,262-6,494,249-1,906,591-1,957,518
CFO
-2m
L+141.97%
-1,262,553-228,585-1,280,866-432,000-1,751,000-2,628,000-1,621,505-1,245,977-930,295-104,861-805,789230,041-701,678-1,013,299-1,015,309-1,618,558-683,095-1,695,411-1,008,569-2,440,446

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Eden BioSolutions Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The firm provides various plant protection products, such as foliar disease control, soil pest, protected glass house crops, and post-harvest applications. It also offers treatment for various pathogens that effect animal health, as well as provides animal health products, such as shampoos, conditioners, odour controls, flea and tick controls, hygiene products, parasite treatments, and insect sprays. The company also offers human health products comprising head-lice, fragrances, wound-care, and food flavorings. It provides a range of natural and synthetic active ingredients, including pesticides, as well as biocides. The company was founded on June 22, 1995 and is headquartered in Abingdon, the United Kingdom.

Key people

Sean Smith
Chief Executive Officer, Executive Director · since 2014
Alex Abrey
Chief Financial Officer, Executive Director, Secretary · since 2015
Lykele Van Der Broek
Non-Executive Independent Chairman of the Board · since 2018
Robin Cridland
Non-Executive Independent Director · since 2018
Derek Mcallan
Non-Executive Independent Director · since 2024
IPO date
May 11, 2012
Employees
19
Domiciled in
GB
Incorporated in
GB
Legal address
6, PRIORY COURT
PRIORY COURT BUSINESS PARK
CIRENCESTER, GLS GL7 5JB
GB
Headquarters
6, PRIORY COURT
PRIORY COURT BUSINESS PARK
Poulton
CIRENCESTER, GLS GL7 5JB
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT